Fig. 2From: Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trialsRisk of bias based on the evaluation elements listed in the Cochrane Collaboration Risk of Bias Tool: risk of bias graph (A), risk of bias summary (B)Back to article page